Pfizer & Wyeth: acquiring to survive, rather than to grow
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/35670 |
Resumo: | This case focus on the strategy that motivated Pfizer to go, by 2009, through the acquisition of Wyeth. Beyond the strategic reasons, this case will discuss the financial implications of the deal jointly analysing the impact on financial key ratios for Pfizer’s investors. As the historical Pfizer’s portfolio of acquisitions is considerably extended, its investors are left with questions about the realization of the synergies announced as well as the ability to integrate Wyeth’s business in such a tough period. |
id |
RCAP_3a2ba5cb3d055371a300fe31fb3afaee |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/35670 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Pfizer & Wyeth: acquiring to survive, rather than to growMergers & acquisitionsCorporate financeDeal financingDomínio/Área Científica::Ciências Sociais::Economia e GestãoThis case focus on the strategy that motivated Pfizer to go, by 2009, through the acquisition of Wyeth. Beyond the strategic reasons, this case will discuss the financial implications of the deal jointly analysing the impact on financial key ratios for Pfizer’s investors. As the historical Pfizer’s portfolio of acquisitions is considerably extended, its investors are left with questions about the realization of the synergies announced as well as the ability to integrate Wyeth’s business in such a tough period.Pinho, PauloRUNEsteves, João Pedro Monsanto2018-04-30T11:32:11Z2018-01-162018-01-16T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/pdfhttp://hdl.handle.net/10362/35670TID:201863936enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:19:26Zoai:run.unl.pt:10362/35670Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:30:20.900949Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Pfizer & Wyeth: acquiring to survive, rather than to grow |
title |
Pfizer & Wyeth: acquiring to survive, rather than to grow |
spellingShingle |
Pfizer & Wyeth: acquiring to survive, rather than to grow Esteves, João Pedro Monsanto Mergers & acquisitions Corporate finance Deal financing Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
title_short |
Pfizer & Wyeth: acquiring to survive, rather than to grow |
title_full |
Pfizer & Wyeth: acquiring to survive, rather than to grow |
title_fullStr |
Pfizer & Wyeth: acquiring to survive, rather than to grow |
title_full_unstemmed |
Pfizer & Wyeth: acquiring to survive, rather than to grow |
title_sort |
Pfizer & Wyeth: acquiring to survive, rather than to grow |
author |
Esteves, João Pedro Monsanto |
author_facet |
Esteves, João Pedro Monsanto |
author_role |
author |
dc.contributor.none.fl_str_mv |
Pinho, Paulo RUN |
dc.contributor.author.fl_str_mv |
Esteves, João Pedro Monsanto |
dc.subject.por.fl_str_mv |
Mergers & acquisitions Corporate finance Deal financing Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
topic |
Mergers & acquisitions Corporate finance Deal financing Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
description |
This case focus on the strategy that motivated Pfizer to go, by 2009, through the acquisition of Wyeth. Beyond the strategic reasons, this case will discuss the financial implications of the deal jointly analysing the impact on financial key ratios for Pfizer’s investors. As the historical Pfizer’s portfolio of acquisitions is considerably extended, its investors are left with questions about the realization of the synergies announced as well as the ability to integrate Wyeth’s business in such a tough period. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-04-30T11:32:11Z 2018-01-16 2018-01-16T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/35670 TID:201863936 |
url |
http://hdl.handle.net/10362/35670 |
identifier_str_mv |
TID:201863936 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137927799767040 |